Home » Topics » Disease categories and therapies » Dental

Dental
RSS

CollaGenex and Merck establish copromotion agreement for Vioxx

Sep. 27, 1999

HRT may slow periodontal disease progression

Aug. 31, 1999

Emdogain approved by FDA for minimally invasive dental surgery

Aug. 13, 1999

CollaGenex signs marketing agreement for Periostat in Canada

July 5, 1999

Study results published for Atridox periodontal therapy

June 25, 1999

First E.U. approval of Atridox for periodontal disease

April 28, 1999

U.K approval of Atrix's periodontal drug delayed

April 16, 1999

Study data on Periodontix's gingivitis treatment reported

March 23, 1999

Actinova enters collaboration for development of tooth decay treatment

Jan. 22, 1999

Pharmacokinetic studies support safety of novel dental agent

Jan. 15, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...